Docosahexaenoic Acid

Norwegians debut 'compressed' omega-3 tablets

Norwegians debut 'compressed' omega-3 tablets

By Shane STARLING

A Norwegian start-up says its patent pending compression technology has allowed it to commercialise omega-3 powder that can be formulated in hard tablets rather than capsules.

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

ONC is strong in omega-3 supplements, but could drug apps hold greater promise?

DSM eyes generic omega-3 drug space with €420m ONC buy

By Shane Starling

DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers